Our core business is all about 37°C, with focus in the field of patient temperature management and specialised in preventing and reducing the effects of hypothermia during anaesthetized patients undergoing treatment or diagnostic surgery. Our PTM portfolio is covering the pre-, per-, and post-intervention period of every patient treated for hypothermia, and it consists of innovative, high quality products. Therefore, we are continually looking to improve and expand our product portfolio. We do so with direct input from Key Opinion Leaders in the field of patient temperature management, who understand the current challenge in reducing the effects of hypothermia.
To expand our valued network, we are looking for Key Opinions Leaders who are known for their experience or publications on patient temperature management, and who sets the Norm/ Level of PTM in their direct environment.
We are delighted to announce that our direct sales force will now support the complete TSC Life product portfolio direct in the UK, which means that with a UK based…
Read article
Launch of TSC Life through the merger of the surgical company’s patient temperature management and single-use endoscopy businesses. Amersfoort, the Netherlands, 30 January 2024 The Surgical Company is excited to…
Read article
From 29 January to 1 February 2024, The Surgical Company Endovision is excited to be attending the Arab Health in Dubai. Our enthusiastic teams will be at booth #S3.C58 .…
Read articleSubscribe to our monthly newsletter containing the latest updates and developments of The Surgical Company
